BROADFOOT JILL MARIE (Chief Financial Officer) sold 7.1% of their position (1.59K shares) of ATYR PHARMA INC on the open market
Open‑market sale worth $2.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/6/2024ACC: 0001209191-24-002947
Officer· Chief Financial Officer
Since Jul 2018
-1.59K
Net shares
Net seller
$2.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.75K acquired · 5.34K disposed
Non-Derivative Transactions2
Common stock
Direct
Shares
+3.75K
Price / share
—
Trade value
—
% of position
20.1%
2/5/2024
18.66K→22.41K
Common stock
Direct
Shares
−1.59K
Price / share
$1.69
Trade value
$2.69K
% of position
7.1%
2/6/2024
22.41K→20.82K
Total
Net shares
+2.16K
Net value
-$2.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 2/5/2024 | M · Option Exercise | +3.75K | — | — | 20.1% | 18.66K | 22.41K |
| Common stock Direct | 2/6/2024 | S · Sale | −1.59K | $1.69 | $2.69K | 7.1% | 22.41K | 20.82K |
| Total | +2.16K | -$2.69K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
3.75K shares
Shares
−3.75K
Strike price
Held after
7.50K
Exercisable
—
2/5/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock3.75K shares | 2/5/2024 | M · Option Exercise | −3.75K | — | 7.50K |